At Drug Development Compliance Consulting LLC, we provide strategic, hands-on regulatory guidance to emerging biopharma companies. With deep expertise in early development, IND/CTA strategy, regulatory risk mitigation, and agency engagement, we help teams such as accelerating timelines, streamlining submissions, and preparing for successful regulatory interactions — all while maintaining a fit-for-purpose compliance framework.
Develop and optimize US/global regulatory strategy (IND/CTA/Orphan/Expedited Pathways)
Identify development gaps and design mitigation plans
Map regulatory risks and agency expectations by modality or indication
Author or QC Module 2 summaries and Module 1 documents
Coordinate with CMC and nonclinical leads to ensure alignment
Drive timelines to submission — from planning to eCTD handoff
Prepare briefing packages and key messaging
Coordinate pre-IND or scientific advice meetings (FDA/EMA)
Provide mock Q&A sessions and meeting rehearsal coaching
Source and manage publishing vendors if needed
Ensure documents meet formatting and regulatory requirements
Track commitments and correspondence post-submission
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.